台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    63.4
  • 漲跌
    ▲0.1
  • 漲幅
    +0.16%
  • 成交量
    237
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-群益金鼎 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/21163.3000.0063.301941.06%
2024/11/20164.4000.0064.401911.10%
2024/11/19269.85170.7069.301881.12%
2024/11/18170.7000.0070.701901.10%
2024/11/15169.80171.4072.6001010.00%
2024/11/14176.50171.4069.7001020.00%
2024/11/13379.27277.5077.401971.02%
2024/10/28196.4000.0096.4011350.74%
2024/09/1200.00296.9096.80-2140-1.43%
2024/09/1100.00295.8096.10-2139-1.44%
2024/08/195107.505106.70106.0001300.00%
2024/08/132104.502104.00101.5001090.00%
2024/08/1200.005102.50102.50-599-5.03%
2024/08/095100.0000.00100.505935.36%
2024/08/0500.00697.0098.80-689-6.69%
2024/08/0200.004100.50100.50-488-4.53%
2024/06/2700.000101.50100.500136-0.01%
2024/05/270104.0000.00102.5001580.01%
2024/05/1510103.6500.00104.00101486.74%
2024/05/032118.501118.00118.5011170.85%
2024/04/100125.0000.00127.000950.00%
2024/04/091124.0000.00124.001771.30%
2024/04/082123.5000.00123.502732.72%
2024/04/021123.0000.00123.501701.41%
2024/04/010123.5000.00123.000690.00%
2024/03/141119.0000.00119.001432.31%
2024/01/0400.001.1114.02114.50-1.125-4.09%
2023/05/1200.001105.50106.50-155-1.80%
2022/12/3000.001108.00108.00-139-2.52%
2022/12/2800.001107.50107.50-139-2.53%
2022/12/2100.000.2103.00103.00-0.238-0.52%
2022/10/211100.0000.00100.001156.42%
2022/10/181100.0000.00101.501146.70%
2022/09/2900.000.3106.00106.00-0.316-1.88%
2022/07/0800.000.199.0098.50-0.143-0.23%
2022/03/240.3130.0000.00129.500.3191.31%
2022/03/230.2131.0000.00130.500.2190.79%
2022/03/220.2131.5000.00131.000.2191.02%
2022/01/0600.000.1126.00125.50-0.123-0.51%
2021/12/2000.002123.25123.50-231-6.32%
2021/07/1300.001151.50150.50-132-3.04%
2021/07/021152.0000.00152.001392.51%
2021/06/2800.001151.00152.00-141-2.39%
2021/06/1800.001152.00152.50-145-2.18%
2021/06/111152.5000.00152.501462.15%
2021/05/061145.0000.00145.001402.49%
2021/04/0900.000146.00145.50035-0.03%
2020/12/031130.501132.50127.000320.00%
2020/11/241119.5000.00119.501342.94%
2020/11/181120.5000.00120.501342.91%
2020/11/1100.002117.50118.00-233-5.94%
2020/06/0400.001109.50112.50-155-1.79%
2020/05/2500.001109.00109.00-153-1.88%
2020/05/221109.0000.00108.501521.89%
2020/05/141109.0000.00108.501492.00%
2020/05/131108.0000.00108.501482.08%
2020/05/1200.001108.00108.00-147-2.11%
2020/05/1100.001106.50106.00-144-2.24%
2020/03/1100.001100.50100.00-128-3.53%
2019/09/2500.002.2101.45102.00-2.234-6.35%
2019/08/281101.5000.00101.501412.40%
2019/07/191102.0000.00103.001442.24%
2018/11/021101.5000.00103.501293.38%
2018/10/191100.0000.0099.801362.77%
2018/09/1700.001105.50106.50-152-1.91%
2018/08/0200.001112.00112.50-169-1.44%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音